OnKure Therapeutics, Inc. Financial Flexibility Index
OnKure Therapeutics, Inc. financial flexibility index. OnKure Therapeutics, Inc. (OKUR) has a Financial Flexibility Index of -1.43x as of June 2026. Free cash flow of $-10.35 Million (operating CF $-10.35 Million minus capex $3.00K) represents -1% of total liabilities ($7.25 Million). See OnKure Therapeutics, Inc. (OKUR) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of OnKure Therapeutics, Inc. (2020–2025)
Financial flexibility index of OnKure Therapeutics, Inc. from 2020 to 2025. Historical Financial Flexibility Index trend for OnKure Therapeutics, Inc. across 6 annual periods. Check earnings quality score of OnKure Therapeutics, Inc. to evaluate the quality of earnings relative to operating cash generation.
OnKure Therapeutics, Inc. Financial Flexibility Index by Year (2020–2025)
OnKure Therapeutics, Inc. financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for OnKure Therapeutics, Inc.. For the full cash flow conversion analysis, see OKUR cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -8.73x | $-51.78 Million | $-51.83 Million | $5.93 Million | ▼ -89.4% |
| 2024 | -4.61x | $-51.06 Million | $-51.12 Million | $11.08 Million | ▼ -1748.7% |
| 2023 | -0.25x | $-34.30 Million | $-34.55 Million | $137.58 Million | ▲ +32.0% |
| 2022 | -0.37x | $-25.82 Million | $-26.95 Million | $70.42 Million | ▲ +93.4% |
| 2021 | -5.55x | $-37.78 Million | $-37.98 Million | $6.81 Million | ▼ -2816.1% |
| 2020 | -0.19x | $-18.51 Million | $-18.54 Million | $97.34 Million | — |